Exagen Inc. (XGN) stock

XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/3015% above fair value

$4.13−0.28 (-6.35%)

Close on Nov 13, 2026Market cap $100.05MP/E –Yield –

Exagen statistics

84 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 9, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $100.05M; $1.68B
Enterprise Value: $94.77M; $2.20B
PS Ratio: 1.38; 1.53
PB Ratio: 7.26; 3.46
P/TBV Ratio: 7.26; 5.80

Enterprise valuationIndustry

EV / Sales: 1.31; 1.67

Share statisticsIndustry

Shares Outstanding: 24M; 59M
Shares Change (YoY): 19.1%; 2.40%
Shares Change (QoQ): 5.07%; 0.33%
Float: 17M; 34M
Shares Held by Insiders: 29.2%; 15.4%
Shares Held by Institutions: 34.1%; 83.6%

Short sellingIndustry

Short Interest: 727,455; –
Short Interest Change: 7.96%; -0.86%
Short % of Float: 4.24%; 6.28%
Short % of Shares Outstanding: 3.00%; 4.21%
Days to Cover: 1.98; 4.41

Stock price statisticsIndustry

52-Week High: $9.73; –
52-Week Low: $2.59; –
20-Day Moving Average: $7.15; –
50-Day Moving Average: $7.71; –
200-Day Moving Average: $5.12; –
Average True Range (14): $0.82; –
Price Change (1 Week): -28.9%; 0.23%
Price Change (1 Month): -51.8%; -0.02%
Price Change (3 Months): -38.4%; 2.13%
Price Change (6 Months): 13.5%; 17.6%
Price Change (YTD): -32.1%; 5.22%
Price Change (1 Year): -56.9%; 3.75%
Price Change (3 Years): 142.9%; 15.2%
Price Change (5 Years): -67.9%; -14.6%
Average Volume (10 Days): 1M; –
Average Volume (20 Days): 701,435; –
Average Volume (90 Days): 423,739; –
Relative Volume: 8.64; 0.70
Relative Strength Index (14): 28.7; 46.0
Volatility (1 Year): 94.6%; 64.2%
Beta (5 Years): 1.17; 0.76

MarginsIndustry

Gross Margin: 58.7%; 33.3%
Operating Margin: -20.1%; -2.98%
Profit Margin: -25.1%; -2.01%
EBITDA Margin: -16.6%; 3.36%
FCF Margin: -18.0%; 2.98%

Returns on capitalIndustry

Return on Equity (ROE): -113.9%; 4.82%
Return on Assets (ROA): -30.8%; -3.10%
Return on Invested Capital (ROIC): -167.2%; 4.69%
Return on Capital Employed (ROCE): -34.4%; 0.40%

Financial positionIndustry

Current Ratio: 3.46; 1.41
Quick Ratio: 3.02; 0.99
Debt / Equity: 1.66; 0.68
Interest Coverage: -2.90; -0.63

GrowthIndustry

Revenue Growth (YoY): 13.7%; 9.63%
Revenue Growth (3Y CAGR): 13.5%; 11.3%
Revenue Growth (5Y CAGR): 9.66%; 12.6%

EfficiencyIndustry

Asset Turnover: 1.22; 0.81
Revenue Per Employee: $328.61K; $235.26K
Profits Per Employee: -$82.60K; -$5.12K
Employee Count: 220; 910
WACC: 11.2%; 8.40%

Income statement (TTM)Industry

Revenue: $72.30M; $638.13M
Gross Profit: $42.46M; $196.31M
Operating Income: -$14.52M; -$675.66K
Net Income: -$18.17M; -$1.48M
EBITDA: -$12.02M; $1.17M
EPS (Diluted): -$0.75; -$0.02

Balance sheetIndustry

Cash & Short-Term Investments: $28.09M; $98.48M
Total Debt: $22.81M; $258.06M
Net Cash (Debt): $5.28M; $203.66K
Net Cash Per Share: $0.22; $0.00
Equity (Book Value): $13.78M; $235.60M
Book Value Per Share: $0.57; $3.91
Tangible Book Value: $13.78M; $1.59M
Working Capital: $32.23M; $30.06M

Cash flow (TTM)Industry

Operating Cash Flow: -$12.02M; $25.90M
Capital Expenditures: -$1.01M; -$15.83M
Free Cash Flow: -$13.03M; $18.83M
FCF Per Share: -$0.54; $0.36

Dividends and yieldsIndustry

Earnings Yield: -18.2%; 0.19%
FCF Yield: -13.0%; 2.55%

Taxes and interestIndustry

Interest Expense: $5.00M; $7.37M
Income Tax: $48.00K; $564.50K

Scores and fair valueIndustry

Altman Z-Score: -5.71; 2.24
Piotroski F-Score: 4; 5
Beneish M-Score: -2.76; -2.76

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	XGN	S&P 500	Difference	XGN per year	S&P 500 per year
1 month	-51.3%	-3.0%	−48.3 pts
3 months	-37.2%	-2.8%	−34.5 pts
Year to date	-32.1%	+11.5%	−43.6 pts
1 year	-55.8%	+13.5%	−69.3 pts
3 years	+182.9%	+77.7%	+105.2 pts	+41.4%	+21.1%
5 years	-67.9%	+72.6%	−140.5 pts	-20.3%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M XGN shares were sold short on Oct 30, 2026, up 8.0% from the previous report, or 4.24% of the shares available to trade. At recent volumes it would take 2.0 days to buy them back. Over the last 20 sessions, 37.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	727,455	+8.0%	366,878	2.0
Oct 15, 2026	673,850	-4.4%	370,013	1.8
Sep 30, 2026	704,634	-12.0%	286,372	2.5
Sep 15, 2026	800,344	-7.4%	223,196	3.6
Aug 31, 2026	864,038	-8.1%	339,503	2.5
Aug 14, 2026	940,432	+4.0%	625,582	1.5
Jul 31, 2026	903,876	-7.7%	216,667	4.2
Jul 15, 2026	978,980	+20.4%	218,562	4.5
Jun 30, 2026	813,368	+28.4%	238,208	3.4
Jun 15, 2026	633,365	-26.8%	339,817	1.9
May 29, 2026	864,742	+20.7%	472,052	1.8
May 15, 2026	716,154	-1.2%	854,143	1.0